Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4

Conditions

Medulloblastoma 2Glioma 2Oligodendroglioma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 76Temozolomide 73Specimen Handling 49Radiotherapy 43Radiosurgery 32Cyclophosphamide 27Bevacizumab 26Radiation 25pembrolizumab 24Biopsy 23Nivolumab 21Carboplatin 16X-Rays 14fludarabine 13Lomustine 13Ipilimumab 13Surgical Procedures, Operative 12Irinotecan 12Vincristine 11Topotecan 11Cisplatin 11Blood Specimen Collection 11trametinib 9dinutuximab 9abemaciclib 9lutetium Lu 177 dotatate 8Immunoglobulin G 8Etoposide 8Doxorubicin 8AZD 6244 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Diphtheria-Tetanus Vaccine × CNS × 90 days × Clear all
NCT06254326 2026-05-27

ADAGiO

University of Florida

Phase 1 Recruiting
12 enrolled
CNS

Brain Neoplasms, Oligodendroglioma

NCT05096481 2026-05-11

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

NCT03334305 2026-04-23

ACTION

University of Florida

Phase 1 Terminated
18 enrolled 11 charts
CNS

Glioma

NCT06514898 2026-04-03

MATCHPOINT

University of Florida

Phase 1 Active not recruiting
12 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡